These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24560875)

  • 1. Antigenicity studies in humans and immunogenicity studies in mice: an MSP1P subdomain as a candidate for malaria vaccine development.
    Cheng Y; Shin EH; Lu F; Wang B; Choe J; Tsuboi T; Han ET
    Microbes Infect; 2014 May; 16(5):419-28. PubMed ID: 24560875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax.
    Cheng Y; Wang Y; Ito D; Kong DH; Ha KS; Chen JH; Lu F; Li J; Wang B; Takashima E; Sattabongkot J; Tsuboi T; Han ET
    Infect Immun; 2013 May; 81(5):1585-95. PubMed ID: 23460511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen.
    Changrob S; Leepiyasakulchai C; Tsuboi T; Cheng Y; Lim CS; Chootong P; Han ET
    Malar J; 2015 Apr; 14():159. PubMed ID: 25889175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
    Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.
    Cheng Y; Wang B; Sattabongkot J; Lim CS; Tsuboi T; Han ET
    Parasitol Res; 2014 Jul; 113(7):2559-68. PubMed ID: 24764159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
    Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
    Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of Pv50, a novel Plasmodium vivax merozoite surface protein.
    Cheng Y; Wang B; Lu F; Ahmed MA; Han JH; Na SH; Ha KS; Park WS; Hong SH; Han ET
    Parasit Vectors; 2019 Apr; 12(1):176. PubMed ID: 30999945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
    Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
    Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium vivax Merozoite Surface Protein 1 Paralog as a Mediator of Parasite Adherence to Reticulocytes.
    Han JH; Cho JS; Cheng Y; Muh F; Yoo WG; Russell B; Nosten F; Na S; Ha KS; Park WS; Hong SH; Han ET
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967091
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
    Soares IS; Oliveira SG; Souza JM; Rodrigues MM
    Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
    Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
    Pandey JP; Morais CG; Fontes CJ; Braga EM
    Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli.
    Dutta S; Ware LA; Barbosa A; Ockenhouse CF; Lanar DE
    Infect Immun; 2001 Sep; 69(9):5464-70. PubMed ID: 11500418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Plasmodium vivax MSP1P-19 is involved in binding of reticulocytes through interactions with the membrane proteins band3 and CD71.
    Zuo S; Lu J; Sun Y; Song J; Han S; Feng X; Han ET; Cheng Y
    J Biol Chem; 2024 May; 300(5):107285. PubMed ID: 38636656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.
    Sachdeva S; Ahmad G; Malhotra P; Mukherjee P; Chauhan VS
    Infect Immun; 2004 Oct; 72(10):5775-82. PubMed ID: 15385477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Erythrocyte Membrane-Associated Antigen, PvTRAg-26 of
    Fan L; Xia J; Shen J; Fang Q; Xia H; Zheng M; Han JH; Han ET; Wang B; Xu Y
    Front Public Health; 2020; 8():148. PubMed ID: 32411650
    [No Abstract]   [Full Text] [Related]  

  • 19. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
    Bargieri DY; Rosa DS; Braga CJ; Carvalho BO; Costa FT; Espíndola NM; Vaz AJ; Soares IS; Ferreira LC; Rodrigues MM
    Vaccine; 2008 Nov; 26(48):6132-42. PubMed ID: 18804504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralog.
    Han JH; Cheng Y; Muh F; Ahmed MA; Cho JS; Nyunt MH; Jeon HY; Ha KS; Na S; Park WS; Hong SH; Shin HJ; Russell B; Han ET
    Sci Rep; 2019 Mar; 9(1):3906. PubMed ID: 30846737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.